triethylenephosphoramide has been researched along with Hematologic Malignancies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Accogli, MA; Costi, S; Denti, M; Fugazzaro, S | 1 |
1 trial(s) available for triethylenephosphoramide and Hematologic Malignancies
Article | Year |
---|---|
Therapeutic education and physical activity are feasible and safe in hematologic cancer patients referred to chemotherapy: results of a randomized controlled trial.
Topics: Exercise; Fatigue; Hematologic Neoplasms; Humans; Pilot Projects; Quality of Life; Triethylenephosphoramide | 2022 |